Zobrazeno 1 - 10
of 26
pro vyhledávání: '"YAN-JIN LIU"'
Autor:
Anju Kumari, Lisa Gesumaria, Yan-Jin Liu, V. Keith Hughitt, Xiaohu Zhang, Michele Ceribelli, Kelli M. Wilson, Carleen Klumpp-Thomas, Lu Chen, Crystal McKnight, Zina Itkin, Craig J. Thomas, Beverly A. Mock, David S. Schrump, Haobin Chen
Publikováno v:
JCI Insight, Vol 8, Iss 5 (2023)
Small cell lung cancer (SCLC) is a recalcitrant malignancy with limited treatment options. Bromodomain and extraterminal domain inhibitors (BETis) have shown promising preclinical activity in SCLC, but the broad sensitivity spectrum limits their clin
Externí odkaz:
https://doaj.org/article/486952269d6442e6887641df9fd39b64
Autor:
Yuan-li Guo, Yan-jin Liu
Publikováno v:
International Journal of Nursing Sciences, Vol 2, Iss 2, Pp 184-189 (2015)
Objective: To determine the relationship between family functioning and depression in primary caregivers of stroke survivors in China. Design: Baseline cross-sectional data from an intervention study for stroke survivors and their families were used.
Externí odkaz:
https://doaj.org/article/a7807a57bc7645a49278dd2f09961f49
Autor:
Yan-Jin Liu, 劉彥槿
104
Power consumption and the volume of test data are popular topics in VLSI Testing field. These are the key factors that will determine the quality of the final data testing results. Built-in self-test (BIST) architecture is a technique which
Power consumption and the volume of test data are popular topics in VLSI Testing field. These are the key factors that will determine the quality of the final data testing results. Built-in self-test (BIST) architecture is a technique which
Externí odkaz:
http://ndltd.ncl.edu.tw/handle/45093217537402040401
Autor:
Beverly A. Mock, Carleen Klumpp-Thomas, Zina Itkin, David S. Schrump, Kelli M. Wilson, Xiaohu Zhang, Yan-Jin Liu, Crystal McKnight, V. Keith Hughitt, Michele Ceribelli, Lu Chen, Anju Kumari, Haobin Chen, Craig J. Thomas, Lisa Gesumaria
PurposeSCLC is a recalcitrant malignancy with limited treatment options. BET inhibitors have shown promising preclinical activity in SCLC, but their broad sensitivity spectrum limits their clinical prospects in this malignancy. Drug combination could
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::39955ab13c6d2969781fa0f1e62d6b5d
https://doi.org/10.1101/2021.11.08.467833
https://doi.org/10.1101/2021.11.08.467833
Publikováno v:
Carcinogenesis. 41:699-710
Metastasis, the movement of cancer cells from one site to another, is responsible for the highest number of cancer deaths, especially in lung cancer patients. In this study, we first identified a prognostic marker of lung adenocarcinoma, TCP-1 β sub
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2133901ddd590310fdef05491f4dfba8
https://doi.org/10.1093/carcin/bgz137
https://doi.org/10.1093/carcin/bgz137
Autor:
Shen-Ming Chen, Namasivayam Dhenadhayalan, King-Chuen Lin, Balamurugan Thirumalraj, Yan Jin Liu, Po-Huang Liang, Tse-Wei Chen
Publikováno v:
Sensors and Actuators. B, Chemical
Graphical abstract
Highlights • A fluorogenic detection of L-Cysteine was investigated using rGO/Au nanohybrids. • The rGO/Au nanohybrids was prepared by one-pot hydrothermal method. • A lower LOD (0.51 nm) was achieved. • Practicality o
Highlights • A fluorogenic detection of L-Cysteine was investigated using rGO/Au nanohybrids. • The rGO/Au nanohybrids was prepared by one-pot hydrothermal method. • A lower LOD (0.51 nm) was achieved. • Practicality o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3e08edfae7c3fa7f195cdca09daa7798
http://europepmc.org/articles/PMC7127153
http://europepmc.org/articles/PMC7127153
Autor:
YU-JUI KUO1,2, YAN-JIN LIU3, TZONG-DER WAY4, SU-YIN CHIANG5, JAUNG-GENG LIN1 jglin@mail.cmu.edu.tw, JING-GUNG CHUNG4,6 jgchung@mail.cmu.edu.tw
Publikováno v:
Experimental & Therapeutic Medicine. Jun2017, Vol. 13 Issue 6, p3388-3396. 9p.
Publikováno v:
Experimental and Therapeutic Medicine
Arsenic trioxide (ATO) is clinically used to treat acute promyelocytic leukemia (APL); however, the therapeutic dose of ATO may prompt critical cardiac side effects. Combination therapy may be used to improve the therapeutic efficiency. To evaluate t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::312cd57641274660d5214ed579a9abe5
http://europepmc.org/articles/PMC5450767
http://europepmc.org/articles/PMC5450767